GlobeImmune, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GBIM research report →
About the company
GlobeImmune, Inc. , a biopharmaceutical firm based in Louisville, Colorado, and founded in 1995 (originally Ceres Pharmaceuticals, Inc. until its rebranding in May 2001), specializes in creating therapeutic products for both cancer and infectious diseases.
- CEO
- Donald Bellgrau
- IPO
- 2014
- Employees
- 2
- HQ
- Louisville, CO, US
Price Chart
- Market Cap
- $575
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 3.84
- Div Yield
- 0.00%
- Gross Margin
- 58.99%
- Op Margin
- -42.85%
- Net Margin
- -42.85%
- ROE
- -64.41%
- ROIC
- -38.00%
- Revenue
- $6.46M · 8.24%
- Net Income
- $-2,766,905 · 86.27%
- EPS
- $-0.48 · 93.05%
- Op Income
- $-2,766,905
- FCF YoY
- 30.74%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -200.46
- Avg Volume
- 540
Get TickerSpark's AI analysis on GBIM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 16, 16 | MITCHELL DANIEL J | sell | 8,862 |
| Mar 17, 16 | MITCHELL DANIEL J | sell | 12,468 |
| Mar 16, 16 | MITCHELL DANIEL J | sell | 112 |
| Mar 17, 16 | MITCHELL DANIEL J | sell | 158 |
| Mar 11, 16 | MITCHELL DANIEL J | sell | 76,662 |
| Mar 15, 16 | MITCHELL DANIEL J | sell | 50,831 |
| Mar 11, 16 | MITCHELL DANIEL J | sell | 2,131 |
| Mar 15, 16 | MITCHELL DANIEL J | sell | 645 |
| Mar 8, 16 | MITCHELL DANIEL J | sell | 5,741 |
| Mar 9, 16 | MITCHELL DANIEL J | sell | 5,643 |
Our GBIM coverage
Recent articles, reports, and earnings notes.
No research on GBIM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GBIM report →Similar companies
Peers in the same neighborhood.